SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
-1.58%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$2.14B
AUM Growth
+$2.14B
(+49%)
Cap. Flow
+$729M
Cap. Flow
% of AUM
34.01%
Top 10 Holdings %
Top 10 Hldgs %
90.45%
Holding
108
New
16
Increased
40
Reduced
26
Closed
13
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$488M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$121M |
| 3 |
Simplify Multi-QIS Alternative ETF
QIS
|
$90M |
| 4 |
Simplify US Equity PLUS Upside Convexity ETF
SPUC
|
$89.1M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
$71.9M |
Top Sells
| 1 |
Simplify Stable Income ETF
BUCK
|
$109M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$25.3M |
| 3 |
DexCom
DXCM
|
$5.91M |
| 4 |
Edwards Lifesciences
EW
|
$5.14M |
| 5 |
Akero Therapeutics
AKRO
|
$4.82M |
Sector Composition
| 1 | Healthcare | 7.09% |
| 2 | Energy | 1.27% |
| 3 | Real Estate | 0.5% |
| 4 | Industrials | 0.18% |
| 5 | Consumer Discretionary | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Achieve Life Sciences
ACHV
$152M
| $582K | 0.02% |
217,845
| – | – |
|
77
Vertex Pharmaceuticals
VRTX
$100B
| $579K | 0.02% |
1,195
-3,494
| -75% | -$1.69M |
|
78
Agilon Health
AGL
$530M
| $481K | 0.02% |
111,096
+576
| +0.5% | +$2.49K |
|
79
EyePoint Pharmaceuticals
EYPT
$797M
| $478K | 0.02% |
+88,155
| New | +$478K |
|
80
Stryker
SYK
$150B
| $451K | 0.02% |
1,212
+6
| +0.5% | +$2.23K |
|
81
TG Therapeutics
TGTX
$4.65B
| $445K | 0.02% |
11,288
+51
| +0.5% | +$2.01K |
|
82
Athira Pharma
ATHA
$15.3M
| $425K | 0.02% |
1,492,792
| – | – |
|
|
TWO
83
Two Harbors Investment
TWO
$1.04B
| $414K | 0.02% |
31,000
+20,000
| +182% | +$267K |
|
84
LivaNova
LIVN
$3.08B
| $371K | 0.01% |
9,446
+49
| +0.5% | +$1.93K |
|
85
Leap Therapeutics
LPTX
$12M
| $290K | 0.01% |
950,973
+4,927
| +0.5% | +$1.5K |
|
86
Zimmer Biomet
ZBH
$21B
| $263K | 0.01% |
2,326
+19
| +0.8% | +$2.15K |
|
87
3M
MMM
$82.8B
| $260K | 0.01% |
1,770
-24,101
| -93% | -$3.54M |
|
88
Sarepta Therapeutics
SRPT
$1.78B
| $259K | 0.01% |
4,054
-28,725
| -88% | -$1.83M |
|
89
Fulcrum Therapeutics
FULC
$351M
| $234K | 0.01% |
81,134
+420
| +0.5% | +$1.21K |
|
90
Chewy
CHWY
$16.9B
| $231K | 0.01% |
7,092
-66,319
| -90% | -$2.16M |
|
91
Compass Therapeutics
CMPX
$483M
| $228K | 0.01% |
+120,000
| New | +$228K |
|
|
QVCGA
92
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $121K | ﹤0.01% |
600,000
| – | – |
|
93
Ardelyx
ARDX
$1.53B
| – | – |
-689,364
| Closed | -$3.5M |
|
|
94
Simplify Stable Income ETF
BUCK
$348M
| – | – |
-4,448,579
| Closed | -$109M |
|
|
CEE
95
Central and Eastern Europe Fund
CEE
$105M
| – | – |
-24,235
| Closed | -$265K |
|
|
CMPS
96
Compass Pathways
CMPS
$424M
| – | – |
-14,248
| Closed | -$53.9K |
|
97
SPDR Gold Trust
GLD
$107B
| – | – |
0
| – | – |
|
98
iShares Bitcoin Trust
IBIT
$80.7B
| – | – |
0
| – | – |
|
99
Jasper Therapeutics
JSPR
$45.5M
| – | – |
-20,000
| Closed | -$428K |
|
100
Kura Oncology
KURA
$686M
| – | – |
-80,000
| Closed | -$697K |
|